BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2025.
World J Gastroenterol. Dec 7, 2025; 31(45): 112926
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.112926
Table 1 Baseline characteristics and comparisons of complete blood count and inflammatory biomarkers between the control and pediatric fistula-in-ano groups
Variable
Total (n = 974)
Control (n = 293)
Case (n = 681)
P value
Z value
Age (months), median IQR12.0 (9.0-31.0)16.0 (12.0-48.0)11.0 (8.0-12.0)< 0.001-19.484
WBC (× 109/L), median IQR8.3 (6.4-11.0)6.0 (4.8-7.0)9.8 (7.8-12.1)< 0.0015.711
NEUT (× 109/L), median IQR2.7 (1.9-3.6)3.0 (2.2-4.1)2.5 (1.9-3.3)< 0.001-23.839
LYMPH (× 109/L), median IQR4.9 (2.7-7.2)2.1 (1.5-2.6)6.2 (4.7-8.1)< 0.001-2.658
MONO (× 109/L), median IQR0.5 (0.4-0.6)0.5 (0.4-0.6)0.5 (0.4-0.6)0.008-17.460
EO (× 109/L), median IQR0.2 (0.1-0.3)0.1 (0.0-0.1)0.2 (0.2-0.4)< 0.001-16.209
BASO (× 109/L), median IQR0.0 (0.0-0.0)0.0 (0.0-0.0)0.0 (0.0-0.0)< 0.00121.915
NLR, median IQR0.5 (0.3-1.1)1.5 (1.0-2.2)0.4 (0.3-0.6)< 0.00116.291
PLR, median IQR66.5 (46.7-90.8)95.5 (74.9-122.0)55.9 (40.5-75.1)< 0.00122.783
MLR, median IQR0.1 (0.1-0.2)0.2 (0.2-0.3)0.1 (0.1-0.1)< 0.00115.205
SII, median IQR169.8 (104.9-267.0)279.4 (192.2-436.4)137.4 (88.7-198.6)< 0.00119.255
SIRI, median IQR0.3 (0.2-0.6)0.7 (0.4-1.1)0.2 (0.1-0.3)< 0.00118.273


Write to the Help Desk